Avantor, Inc.
AVTR
Updated: 24/09/2026, 10:05:06
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
No summaries found.
- Share price
- $14.76
- Market cap
- $9.98B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Emmanuel Ligner
- Employees
- 13,500
- IPO date
- 17/05/2019
- Beta
- 0.895
- Last dividend
- $0.00
- Day range
- $14.72 – $15.14
- 52-week range
- $7.27 – $16.05
- 1-day performance
- -1.20%
- 1-year performance
- 103.17%
- Current drawdown (1Y)
- -8.04%
- CIK
- 0001722482
- CUSIP
- 05352A100
- ISIN
- US05352A1007
- Created
- 07/12/2025, 02:53:23
- Last update
- 24/09/2026, 10:05:06
Track Avantor, Inc. with an AI analyst
See which prediction-market events move AVTR, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Why Is Avantor (AVTR) Up 13% Since Last Earnings Report?
Zacks Investment Research • STOCK • 29/05/2026, 14:32:10
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
Zacks Investment Research • STOCK • 29/05/2026, 14:11:05
Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory
PRNewsWire • STOCK • 19/05/2026, 08:05:00
Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline
Zacks Investment Research • STOCK • 30/04/2026, 15:40:36
Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 29/04/2026, 15:12:00
Avantor, Inc. (AVTR) Q1 Earnings and Revenues Top Estimates
Zacks Investment Research • STOCK • 29/04/2026, 10:46:37
Avantor® Reports First Quarter 2026 Results
PRNewsWire • STOCK • 29/04/2026, 08:05:00
Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer
PRNewsWire • STOCK • 23/04/2026, 19:05:00
Avantor Expands Masterflex Portfolio to Streamline Bioprocessing
Zacks Investment Research • STOCK • 22/04/2026, 15:41:07
Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm
GlobeNewsWire • STOCK • 22/04/2026, 11:32:00
Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing
PRNewsWire • STOCK • 21/04/2026, 10:05:00
Avantor® Enhances U.S. Biomanufacturing Infrastructure with Expanded Stability and Microbial Testing Facility
PRNewsWire • STOCK • 13/04/2026, 10:05:00